Legislation
- Title
- Investigational Drugs, Biological Products, and Devices - Right to Try Act
- Sponsored by
- Senators Simonaire, Middleton, Astle, Benson, Feldman, Hershey, Jennings, Klausmeier, Mathias, Oaks, Reilly, and Rosapepe
- Status
- In the House - House Refuses to Recede
- Analysis
- Fiscal and Policy Note (Revised)
Synopsis
Authorizing a manufacturer of an investigational drug, biological product, or device to make available the investigational drug, biological product, or device to eligible patients; requiring a manufacturer of an investigational drug, biological product, or device to notify a specified patient and a specified health care provider of specified side effects or risks; requiring the Office of the Attorney General to develop an informed consent form that meets specified requirements; etc.
Committees
- Original:
- Finance Click to view Recorded Media
- Opposite:
- Health and Government Operations
Details
History
Toggle History Dropdown
File Code
Toggle Filecode Dropdown
Subjects
Toggle Subjects Dropdown
Statutes
Toggle Statutes Dropdown
(
21-2B-01 through 21-2B-06 )
Last Updated: 2/3/2020 2:34 PM